Maharashtra FDA ex-chief accuses DCGI of delaying action against J&J

In a telephonic interview to ET, Zagade also questioned the basis on which the drug controller’s office re-issued the import licence for the articular surface replacement (ASR) hip implants even though the company had voluntarily recalled the product in 2010.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2PeOD5h
via IFTTT